CIK 0001828673 · <br>Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825024477
- Phone
- 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-14 | Byam Rebecca Chief Financial Officer | Purchase | +58,856 | $2.46 | $145K | 155,452 |
| 2022-06-13 | Byam Rebecca Chief Financial Officer | Purchase | +7,596 | $2.08 | $16K | 96,596 |
| 2022-06-10 | Wong Hing C Chief Executive Officer | Purchase | +1,520 | $2.19 | $3K | 15,286,468 |
| 2022-06-10 | Winer Gary M Director | Purchase | +1,500 | $2.13 | $3K | 13,000 |
| 2022-06-09 | Winer Gary M Director | Purchase | +1,000 | $2.20 | $2K | 11,500 |
| 2022-06-09 | Wong Hing C Chief Executive Officer | Purchase | +2,000 | $2.25 | $4K | 15,284,948 |
| 2022-06-08 | Winer Gary M Director | Purchase | +1,000 | $2.27 | $2K | 10,500 |
| 2022-06-07 | Wong Hing C Chief Executive Officer | Purchase | +1,000 | $2.31 | $2K | 15,282,948 |
| 2022-06-07 | Winer Gary M Director | Purchase | +1,000 | $2.10 | $2K | 9,500 |
| 2022-06-06 | Winer Gary M Director | Purchase | +1,000 | $2.13 | $2K | 8,500 |
| 2022-06-02 | Greene Rick S. Director | Purchase | +4,800 | $2.09 | $10K | 8,411 |
| 2022-05-31 | Jiao Jin-an VP of Development | Option exercise | +12,856 | $0.14 | $2K | 43,427 |
| 2022-05-31 | Jiao Jin-an VP of Development | Option exercise | +1,714 | $0.21 | $360 | 45,141 |
| 2022-05-31 | Jiao Jin-an VP of Development | Option exercise · Stock Option (Right to Buy) | −12,856 | 18,001 | ||
| 2022-05-31 | Jiao Jin-an VP of Development | Option exercise · Stock Option (Right to Buy) | −1,714 | 6,857 | ||
| 2022-01-14 | Rhode Peter See Remarks | Option exercise | +1,714 | $0.21 | $360 | 48,499 |
| 2022-01-14 | Rhode Peter See Remarks | Option exercise | +1 | $0.14 | $0 | 48,500 |
| 2022-01-14 | Rhode Peter See Remarks | Option exercise · Stock Option Grant (Right to Buy) | −1,714 | 6,857 | ||
| 2022-01-14 | Rhode Peter See Remarks | Option exercise · Stock Option Grant (Right to Buy) | −1 | 51,427 | ||
| 2021-12-06 | Jiao Jin-an VP of Development | Purchase | +10,000 | $2.42 | $24K | 30,571 |
Page 6 of 9 · 164 trades